“The time is right to unleash a new wave of advances,” declared President Obama during a White House speech Friday, January 30, in which he unveiled details of his new Precision Medicine Initiative. The $215 million plan includes funding for the National Cancer Institute to enhance its efforts to find genetic factors that lead to cancer and to develop new and more effective therapies; for the Food and Drug Administration to modernize regulations; and for the National Institutes of Health to recruit a research group of one million volunteers, in order to analyze genomic and other health data—while working closely with patient privacy advocates. The FNIH congratulates President Obama for a bold effort to change millions of lives through a commitment to biomedical research, and we stand ready to assist this important initiative.
Watch the President’s speech here >>.
Donate and Support Today
Take Action to Support Life-Saving Medical Research
Every dollar counts! Your gift to the FNIH makes our efforts possible. With your help—and in partnership with NIH—the Foundation is advancing biomedical research and training.
Donate with Confidence
For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards.
News and Highlights
Inadequate nutrition has been associated with half of deaths worldwide in children under age five. In addition, write investigators from the MAL-ED Network in a special section of the November 1 edition of Clinical Infectious Diseases, the long-term effects of “undernutrition” in young children “have been associated with cognitive and physical growth deficits across multiple generations and have been thought to suppress immunity to further infections and to reduce the efficacy of childhood vaccines. More >>
In 2015, NIH will become one of a select group of institutions of higher learning taking part in the Amgen Scholars Program. ThIs program is made possible by an $850,000 grant to the Foundation for the NIH from the Amgen Foundation. More >>
FNIH is pleased to announce a collaboration with ICON, plc to Develop a New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials.
The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. More >>